Matinas Biopharma Holdings Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 65.17 K | $32.59 K | 16.44% | 1.19% |
| CITADEL ADVISORS LLC | 05/15/2026 | 51.70 K | $25.85 K | -21.35% | 0.94% |
| BLACKROCK, INC. | 05/13/2026 | 49.65 K | $24.83 K | 0.00% | 0.91% |
| 05/15/2026 | 40.11 K | $20.06 K | 100.00% | 0.73% | |
| HOLOS INTEGRATED WEALTH LLC | 04/08/2026 | 32.48 K | $16.32 K | 0.00% | 0.59% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 28.57 K | $14.29 K | -1.38% | 0.52% |
| XTX TOPCO LTD | 05/15/2026 | 20.71 K | $10.35 K | 22.46% | 0.38% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 18.28 K | $9.14 K | 100.00% | 0.33% |
| STATE STREET CORP | 05/15/2026 | 15.32 K | $7.66 K | 0.00% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 14.33 K | $7.16 K | -32.14% | 0.26% |
| SARGENT INVESTMENT GROUP, LLC | 05/11/2026 | 12.72 K | $6.36 K | 0.00% | 0.23% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 2.85 K | $1.43 K | -0.28% | 0.05% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 1.34 K | $669 | 100.00% | 0.02% |
| MORGAN STANLEY | 05/15/2026 | 344 | $172 | -38.68% | 0.01% |
| COSTELLO ASSET MANAGEMENT, INC | 04/30/2026 | 200 | $100 | 0.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 184 | $92 | -69.69% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 102 | $51 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 61 | $31 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 05/15/2026 | 60 | $34 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 05/18/2026 | 60 | $30 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 50 | $25 | 0.00% | 0.00% |
| VISION FINANCIAL MARKETS LLC | 04/24/2026 | 40 | $20 | 0.00% | 0.00% |
| ROTHSCHILD INVESTMENT LLC | 05/07/2026 | 14 | $7 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 11 | $6 | 0.00% | 0.00% |
| FMR LLC | 05/15/2026 | 7 | $4 | 100.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 5 | $3 | -98.82% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 2 | $1 | 0.00% | 0.00% |
| BOGART WEALTH, LLC | 04/28/2026 | 2 | $1 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
Matinas Biopharma Holdings Inc institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Matinas Biopharma Holdings Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 65,170
CITADEL ADVISORS LLC: 51,698
BlackRock, Inc.: 49,650
Holos Integrated Wealth LLC: 32,480
RENAISSANCE TECHNOLOGIES LLC: 28,570
XTX Topco Ltd: 20,706
6.47% of Matinas Biopharma Holdings Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.57 M shares in the last 24 months. This purchase volume represents approximately $2.14 M in transactions.